You have 8 free searches left this month | for more free features.

navtemadlin (KRT-232)

Showing 1 - 25 of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Cancer Trial (Navtemadlin, Navtemadlin Placebo)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Mar 21, 2023

Non Small Cell Lung Cancer Trial (Navtemadlin, Navtemadlin Placebo, Pembrolizumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Jan 27, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Merkel Cell Carcinoma Trial in Worldwide (KRT-232, Avelumab)

Recruiting
  • Merkel Cell Carcinoma
  • Aurora, Colorado
  • +38 more
Aug 3, 2022

Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)

Recruiting
  • Resectable Soft Tissue Sarcoma
  • Soft Tissue Sarcoma
  • Goodyear, Arizona
  • +52 more
Jul 21, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma, Small Cell Lung Cancer Extensive Stage Trial in Worldwide (KRT-232)

Recruiting
  • Small-cell Lung Cancer
  • +3 more
  • Fort Myers, Florida
  • +29 more
Jun 15, 2022

Acute Myeloid Leukemia Trial in Worldwide (TL-895, KRT-232)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +33 more
Aug 3, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022

Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Birmingham, Alabama
  • +25 more
Mar 4, 2022

Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Birmingham, Alabama
  • +155 more
Aug 12, 2022

Polycythemia Vera Trial in Worldwide (KRT-232, Ruxolitinib)

Unknown status
  • Polycythemia Vera
  • Birmingham, Alabama
  • +15 more
Jul 30, 2020

Proenkephalin A and Kidney Replacement Therapy

Suspended
  • Acute Kidney Injury
  • None planned
  • Gießen, Hessen, Germany
    University Hospital Gießen and Marburg
Jan 23, 2023

Acute Side Effects In Stage III NSCLC With Definitive CRT

Completed
  • Non-small Cell Lung Cancer Stage III
    • Ankara, Turkey
      Ankara University Medicine School Radiation Oncology
    Aug 22, 2023

    Healthy Subjects Trial in Adelaide, Nedlands (PN-232, Placebo)

    Completed
    • Healthy Subjects
    • Adelaide, South Australia, Australia
    • +1 more
    Sep 30, 2022

    Acute Kidney Injury in Coronavirus Disease-19 Patients Admitted

    Active, not recruiting
    • Critical Illness
    • +2 more
    • Observational study exploring the epidemiology and outcomes of AKI in critical COVID-19 patients admitted to the ICU
    • Antwerp, Belgium
    • +8 more
    Jan 21, 2022

    ICU Patients With Acute Kidney Injury

    Recruiting
    • Delirium
    • +5 more
    • Cerebral oxygenation
    • Kingston, Ontario, Canada
      Kingston Health Sciences Centre
    Apr 18, 2022

    Covid19 Trial in Tbilisi (ADAPT-232 oral solution, Placebo oral solution)

    Completed
    • Covid19
    • ADAPT-232 oral solution
    • Placebo oral solution
    • Tbilisi, Georgia
      National Family Medicine Training Centre,
    Dec 27, 2021

    Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in France, Netherlands, United States (AMG 232)

    Completed
    • Advanced Malignancy
    • +7 more
    • AMG 232
    • Santa Monica, California
    • +13 more
    Aug 30, 2021

    GDM, Gestational Diabetes, Nutritional and Metabolic Diseases Trial in Herlev (Dietary treatment)

    Not yet recruiting
    • GDM
    • +4 more
    • Dietary treatment
    • Herlev, Denmark
      Steno Diabetes Center Copenhagen
    Nov 8, 2023

    Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Australia, United States (AMG 232, Trametinib, Dabrafenib)

    Completed
    • Advanced Malignancy
    • +6 more
    • AMG 232
    • +2 more
    • Los Angeles, California
    • +6 more
    Mar 24, 2021

    Atrial Fibrillation, Heart Diseases Trial in Moscow (Thoracoscopic surgical ablation)

    Active, not recruiting
    • Atrial Fibrillation
    • Heart Diseases
    • Thoracoscopic surgical ablation
    • Moscow, Russian Federation
    • +1 more
    Jan 24, 2023

    Pain Trial in Belgium, Denmark, United States (bupivacaine liposome injectable suspension, Placebo)

    Completed
    • Pain
    • bupivacaine liposome injectable suspension
    • Placebo
    • Mobile, Alabama
    • +16 more
    Nov 6, 2020

    Prostate Adenocarcinoma Trial in Navi-Mumbai (Moderate Hypo-fractionation, Extreme Hypo-fractionation)

    Recruiting
    • Prostate Adenocarcinoma
    • Moderate Hypo-fractionation
    • Extreme Hypo-fractionation
    • Navi-Mumbai, Maharashtra, India
      Dr Vedang Murthy
    Mar 27, 2021